M Usami

510 total citations
37 papers, 397 citations indexed

About

M Usami is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, M Usami has authored 37 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 7 papers in Oncology. Recurrent topics in M Usami's work include Prostate Cancer Treatment and Research (16 papers), Cancer, Lipids, and Metabolism (5 papers) and Cancer Diagnosis and Treatment (5 papers). M Usami is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Cancer, Lipids, and Metabolism (5 papers) and Cancer Diagnosis and Treatment (5 papers). M Usami collaborates with scholars based in Japan, United Kingdom and Australia. M Usami's co-authors include F. WADA, Hideyuki Akaza, Tadashi Tsukamoto, Shunsuke Kagawa, Seiji Naito, Shiro Hinotsu, Masaru Murai, Tadaichi Kitamura, Osamu Ogawa and Hideyuki Akaza and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Tetrahedron.

In The Last Decade

M Usami

34 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Usami Japan 10 272 95 71 69 66 37 397
Claude Darte United States 9 219 0.8× 115 1.2× 77 1.1× 35 0.5× 111 1.7× 15 517
Young Sun Lee United States 10 370 1.4× 125 1.3× 54 0.8× 111 1.6× 133 2.0× 17 580
H. S. Levin United States 9 181 0.7× 133 1.4× 39 0.5× 38 0.6× 84 1.3× 15 396
Li Yan Khor Singapore 11 272 1.0× 173 1.8× 28 0.4× 94 1.4× 114 1.7× 36 470
S. Eckhardt Hungary 12 79 0.3× 113 1.2× 78 1.1× 54 0.8× 134 2.0× 44 397
Santhi Gladson United States 15 557 2.0× 199 2.1× 31 0.4× 85 1.2× 64 1.0× 25 742
Marjan Emami Canada 8 128 0.5× 132 1.4× 47 0.7× 49 0.7× 55 0.8× 11 324
H Schweisfurth Germany 14 271 1.0× 148 1.6× 43 0.6× 23 0.3× 249 3.8× 39 572
P. Stattin Sweden 7 257 0.9× 186 2.0× 66 0.9× 160 2.3× 184 2.8× 17 512
Cristina Fhied United States 11 111 0.4× 123 1.3× 38 0.5× 61 0.9× 83 1.3× 27 318

Countries citing papers authored by M Usami

Since Specialization
Citations

This map shows the geographic impact of M Usami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Usami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Usami more than expected).

Fields of papers citing papers by M Usami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Usami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Usami. The network helps show where M Usami may publish in the future.

Co-authorship network of co-authors of M Usami

This figure shows the co-authorship network connecting the top 25 collaborators of M Usami. A scholar is included among the top collaborators of M Usami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Usami. M Usami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsukamoto, Tadashi, Nobuo Shinohara, Norihiko Tsuchiya, et al.. (2010). Phase III Trial of Everolimus in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from RECORD-1. Japanese Journal of Clinical Oncology. 41(1). 17–24. 40 indexed citations
2.
Ranson, Malcolm, Richard H. Wilson, Joe M. O’Sullivan, et al.. (2010). Pharmacokinetic and tolerability profile of once-daily zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancer. International Journal of Clinical Pharmacology and Therapeutics. 48(11). 708–717. 5 indexed citations
4.
Hinotsu, Shiro, Hideyuki Akaza, M Usami, et al.. (2007). Current Status of Endocrine Therapy for Prostate Cancer in Japan Analysis of Primary Androgen Deprivation Therapy on the Basis of Data Collected by J-CaP. Japanese Journal of Clinical Oncology. 37(10). 775–781. 53 indexed citations
5.
Akaza, Hideyuki, Hideki Yoshida, Y Takimoto, et al.. (2005). Bicalutamide 80 mg in combination with an LHRHa versus LHRHa monotherapy in previously untreated advanced prostate cancer: a double-blind, placebo-controlled trial. Journal of Clinical Oncology. 23(16_suppl). 4648–4648. 2 indexed citations
6.
Akaza, Hideyuki, M Usami, Shiro Hinotsu, et al.. (2004). Characteristics of Patients with Prostate Cancer Who Have Initially been Treated by Hormone Therapy in Japan: J-CaP Surveillance. Japanese Journal of Clinical Oncology. 34(6). 329–336. 46 indexed citations
8.
Hosokawa, Yuki, Toshiaki Kinouchi, Yuka Sawai, et al.. (2002). Renal angiomyolipoma with minimal fat. International Journal of Clinical Oncology. 7(2). 120–123. 29 indexed citations
9.
Kotake, T, M Usami, Hideyuki Akaza, et al.. (1999). Goserelin Acetate with or without Antiandrogen or Estrogen in the Treatment of Patients with Advanced Prostate Cancer: A Multicenter, Randomized, Controlled Trial in Japan. Japanese Journal of Clinical Oncology. 29(11). 562–570. 27 indexed citations
10.
Imamura, Ryoichi, Toshiaki Kinouchi, Muneya Fujimoto, et al.. (1998). [Bilateral synchronous adrenal myelolipomas: a case report].. PubMed. 44(11). 801–3. 5 indexed citations
11.
Imamura, Ryoichi, Mao Fujimoto, Norio Meguro, et al.. (1998). [Labial adhesion presenting as urinary incontinence and dysuria in a postmenopausal woman: a case report].. PubMed. 44(11). 843–5. 8 indexed citations
12.
Meguro, Norio, Osamu Maeda, Shinji Saiki, et al.. (1996). [Prostatic cancer with cystic formation: a case report].. PubMed. 42(12). 977–80. 1 indexed citations
13.
Saiki, Shinji, Toshiro Kinouchi, Norio Meguro, et al.. (1995). [Multicentricity and concomitant tumors in renal cell carcinoma: analysis by serial section of resected kidneys].. PubMed. 41(9). 725–9. 3 indexed citations
14.
Kinouchi, Toshiaki, Terukiyo Hanafusa, M. Kuroda, M Usami, & T Kotake. (1995). Case Reports. The Journal of Urology. 153(3 Pt 2). 1049–1050. 3 indexed citations
15.
Usami, M, et al.. (1990). [A case report of cutaneous seeding of hepatocellular carcinoma following ultrasound guided fine needle aspiration biopsy].. PubMed. 87(5). 1253–7. 9 indexed citations
16.
Usami, M, T Kotake, Michiyuki Matsuda, et al.. (1988). [Endocrine therapy of prostatic carcinoma with slow release (depot) formulation of the LH-RH analog ICI 118630 (Zoladex)].. PubMed. 34(2). 369–82. 2 indexed citations
17.
Usami, M, T Kotake, Michiyuki Matsuda, et al.. (1988). [Endocrine therapy for prostatic carcinoma--the clinical trial to compare the efficacy of LH-RH analogue, ICI 118630 (Zoladex) with castration or estrogen].. PubMed. 34(10). 1853–63. 2 indexed citations
18.
Usami, M, et al.. (1987). [Clinical effect of slow release (depot) formulation of the LH-RH analogue ICI 118630 (Zoladex) in patients with prostatic carcinoma].. PubMed. 33(1). 141–50. 1 indexed citations
19.
Akaza, Hideyuki, M Usami, T Kotake, et al.. (1987). [Response criteria for prostatic cancer treated by chemotherapy or antiandrogenic therapy].. PubMed. 33(6). 894–904. 2 indexed citations
20.
Saiki, Shinji, Hironobu Hamada, Shigeki Nabeshima, et al.. (1987). [A case of signet ring cell carcinoma of the urinary bladder].. PubMed. 33(6). 940–4. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026